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Abstract
Aims: The influences of nonstationarity and nonlinearity on heart rate time series can be mathematically qualified or
quantified by multiscale entropy (MSE). The aim of this study is to investigate the prognostic value of parameters derived
from MSE in the patients with systolic heart failure.
Methods and Results: Patients with systolic heart failure were enrolled in this study. One month after clinical condition
being stable, 24-hour Holter electrocardiogram was recording. MSE as well as other standard parameters of heart rate
variability (HRV) and detrended fluctuation analysis (DFA) were assessed. A total of 40 heart failure patients with a mea age
of 56616 years were enrolled and followed-up for 6846441 days. There were 25 patients receiving b-blockers treatment.
During follow-up period, 6 patients died or received urgent heart transplantation. The short-term exponent of DFA and the
slope of MSE between scale 1 to 5 were significantly different between patients with or without b-blockers (p=0.014 and
p=0.028). Only the area under the MSE curve for scale 6 to 20 (Area6–20) showed the strongest predictive power between
survival (n=34) and mortality (n=6) groups among all the parameters. The value of Area6–20!21.2 served as a significant
predictor of mortality or heart transplant (p=0.0014).
Conclusion: The area under the MSE curve for scale 6 to 20 is not relevant to b-blockers and could further warrant
independent risk stratification for the prognosis of CHF patients.
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Introduction
Congestive heart failure (CHF) remains to be one of the
major cardiovascular disorders in the world [1]. Despite its
high expenditure in healthcare budgets [2], the mortality rate
of CHF patients can be up to 8 times higher than the age-
matched control population [3]. The present treatment
protocols of CHF patients, such as administrating angiotensin
converting enzyme inhibitors (ACE-I) and b blockers, have
been proven to lower the mortality and hospital admission rate
[4]. Nevertheless, the residual risk for mortality and morbidity
of CHF remains high even under such treatment protocols
[5,6]. Therefore, further novel prognostic predictor is needed to
strengthen the treatment strategy in addition to neurohormonal
inhibition therapy.
Conventional linear heart rate variability (HRV) analyses,
including frequency and time domain analyses, have been
reported as prognostic factors for CHF [7,8]. However, heart
rate fluctuations have been recognized as complex behaviors
originated from nonlinear processes and often with nonstationary
property [9–11]. Applying linear algorithms to those seemingly
irregular and ‘‘patchy’’ patterns of heart rate fluctuations [12]
may cause the intrinsic computational errors of the linear
algorithms [11,13,14]. Properly use of the analyses based on
fractals and chaos theory [15–17] to qualify or quantify the
characteristics of heart rate time series are suggested to serve as a
more reliable index of physiological systems in many clinical
studies [10,11,18]. As one of such mathematic methods,
multiscale entropy (MSE) analysis has focused specifically on
characterizing heterogeneous complexity [19]. Such complex
structure is ‘‘breakdown’’ (loss of information richness) and
points to poor prognosis in CHF patients [19,20]. We
hypothesized that MSE could yield a prognostic marker which
was not relevant to neurohormonal inhibition therapy in CHF
patients. The aims of this study were 1) to evaluate the influences
of b-blockers on parameters derived from MSE; 2) to assess the
prognostic significance of parameters derived from MSE for
CHF patients.
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Study Population
Patients with manifestation of exertional dyspnea, leg edema
and systolic heart failure (LVEF,45% by echocardiography) at
the National Taiwan University Hospital were enrolled after
giving their inform consents. Baseline information, including age,
sex, etiologies for heart failure,diabetes mellitus, hypertension,
dyslipidemia (total cholesterol .220 mg/dl), and cardiovascular
medication use (b-blockers, ACE-I, angiotensin-II receptor
blockers, and spironolactone) was reviewed in medical records
and charts. Patients with renal dysfunction (defined by creati-
ne§2.0 mg/dl) were excluded. One month after clinical condition
being stable, standard ambulatory 24-hour electrocardiogram
(ECG) recorders were placed on all participants. The ECG signals
were sampled at 250 Hz and stored in SD memory card for offline
analysis on a microcomputer. Subsequently, these patients were
followed up and mortality or heart transplantation will be noted as
end-point for follow-up. The Ethics Committee of National
Taiwan University Hospital approved the study and all patients
provided written informed consent.
Data pre-processing
Each digitalized 24-hour ECG data was annotated by an
automated algorithm and the annotated file was then carefully
inspected and corrected by technicians for extracting the RR
intervals. The ectopic beats (including atrial or ventricular
premature beats) were interpolated by its adjacent RR intervals.
A four-hour period of RR intervals in daytime (between 9AM–
5PM) was selected from each recording to avoid confounding
effects on nonlinear or linear analysis caused by different sleep
stage or diurnal rhythm [21,22]. Only subjects consisted of more
than 80% of qualified normal sinus beats were included for further
analysis (the typical RR-interval tracings and the corresponding
recurrent plots for survival and mortality groups (Figure S1) as well
as all of the RR-interval data are provided as supplementary
materials (Materials S1)).
Time and frequency domain analysis
Standard deviation of normal RR intervals (SDNN) and
percentage of absolute differences in normal RR intervals greater
than 50 ms (pNN50) were calculated to represent the total variance
and vagal modulation of the HR. In addition, the spectrum
analysis was carried out in accordance with the recommendations
of the European Society of Cardiology and the North American
Society of Pacing Electrophysiology [23]. The spectral density of
each frequency band-high frequency (HF) (0.15–0.4 Hz), low
frequency (LF) (0.04–0.15 Hz), and very low frequency (VLF)
(0.003–0.04) were computed by average power spectrum.
Nonlinear methods
Nonlinear analysis enables the researchers to probe the
fundamental characteristics of the signals. However, unwanted
inferences such as noise and nonstationarity may introduce
spurious features to the signals [24,25]. The underlying mecha-
nisms of the irregular and unpredicted behavior of the signals can
be misinterpreted and the reliability of the results of analysis can
be compromised. Two methods had been chosen for their ability
to evaluate the main properties of the signals [14,26].
Detrended fluctuation analysis (DFA)
DFA is a modified root-mean-square analysis used to evaluate
the fractal correlation beneath the heart rate fluctuation originated
from the interacted regulatory mechanisms. The algorithm has
been described in detail elsewhere [14]. To briefly introduce this
method, at first, it eliminates the environmental inferences by
removing the linear-fitted ‘‘local’’ trend over different time scales
(‘‘box sizes’’) in an integrated time series. Next, the root-mean-
square fluctuation of this integrated and detrended time series is
calculated. This procedure is repeated over different time scales
and then the slope of the curve (a exponent) can be estimated on
the log-log plot of fluctuations versus box sizes.
In addition, a crossover phenomenon of a exponent in heart
rate dynamics between short (4–11 beats) and long (11–64 beats)
time scales has been proposed. The short-term (a1) as well as long-
term (a2) fractal correlation exponents were calculated to provide
better understanding of the fractal correlation property in
physiological system [14].
MSE analysis
Instead of simply using single time scale to estimate the complex
pattern (irregularity) of a time series, MSE extended this concept to
evaluate the complexity of physiological signals on multiple time
scales. It comprises of two steps: 1) coarse-graining the signals into
different time scales; 2) quantify the degree of irregularity in each
coarse-grained time series using sample entropy (SpEn) [27].
Finally, the entropy is calculated as a function of scale, providing
a measure of information richness embedded in different time
scales. In addition, it has shown that different features of small and
large scales in different groups of subjects may assist the clinical
categorization [19] and thus three different parameters were
derived from the MSE profile: the summations of quantitative
values of scale 1–5 (Area5) or scale 6–20 (Area6–20) which represent
the complexity exhibit in short and long time scales, respectively;
and the linear-fitted slope of the first 5 scales (Slope5) (Figure 1).
Although MSE was successfully applied in physiological signals
[18,19,24], nonstationary artifacts especially trends can compro-
mise the estimation of entropy-based analysis by increasing the
standard deviation of the data. Hence, detrending process was used
to attenuate the spurious influence caused by nonstationarity [24].
Figure 1. Demonstrative graph of MSE derived parameters. The
profile of MSE can be assessed by a) its linear-fitted slope between
certain scales which represent the complexity behaviors of the signals.
The negative slope may indicate a random-like structure over certain
timescale. B) the area under curve between certain scales that may
represent its quantitative feature of the underlying physiological
mechanisms in certain time scales (ex. area under scale1,5 may
respond to the ability of respiratory sinus arrhythmia).
doi:10.1371/journal.pone.0018699.g001
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was adopted as an adaptive filter to eliminate the oscillations
slower than VLF range in the original R-R interval signals [28].
The data subsequently evaluated by the MSE analysis after
detrending. This algorithm, instead of removing trend with a priori
mathematical formulas such as linear or polynomial functions
[14,29], could evaluate the hidden dynamics of heart beat
fluctuations better [9,10,29].
Statistical analysis
For the independence of different nominal variables between
groups, the chi-square test or Fisher exact test were performed.
The continuous variables were represented as mean value 6 SD
and the normality of those variables was evaluated by using the
Shapiro-Wilk test. Then, the Mann-Whitney U test or Student’s t
test was applied to the between-group comparison accordingly
while the Wilcoxon sign test or Student’s paired t test was
calculated for the intra-group comparison. The receiver operating
characteristic curve (ROC) was constructed by the sensitivity and
specificity of the continuous variable in predicting the end-point.
Area under the ROC curve (AUCs) gave an estimate of the overall
discriminate ability. Furthermore, the most predictive indexes will
be selected to seek the optimal cut point within the 30
th to 70
th
percentile for all patients in 5
th-percentile step. The maximal
hazards ratio and independent correlation of variables with event
status (mortality) was determined by Cox regression analysis.
Then, Kaplan-Meier event probability curves and log rank
analysis of the dichotomized groups were obtained. The statistical
significance was set at p,0.05.
Results
Characteristics of Patients
A total of 40 heart failure patients (30 males and 10 females)
with a mean age of 56616 years were enrolled and followed-up for
6846441 days. Twenty-five patients received b-blockers (either
carvedilol or metoprolol). Carvedilol was titrated from 3.25 mg
per day and metoprolol was titrated from 12.5 mg per day to
maximal tolerable doses. Six patients died or received heart
transplantation during follow-up period of this study. The
demographic and clinical data were showed in Table 1. No
clinical variable was significantly different between these two
groups (with or without b-blocker therapy).
Effect of b-blockers on autonomic activities and its fractal
properties
While the conventional HRV measurements showed no
significant different between these two groups, DFAa1 showed
significantly higher values (p=0.014) in patients with b-blocker
treatment (Table 2).
Effect of b-blockers on the dynamical complexity
assessed by the MSE analysis
There was no significant difference when any single sample
entropy value of scales 1 to 20 was compared between patient
groups with or without b-blockers. However, the value of Slope5
was not only significantly lower (p=0.028) in patients without b-
blocker therapy but also exhibit a negative value (Table 2).
Application of MSE in prognostic prediction
Among all parameters, Area5, Area6–20, and LF were
significantly lower (p=0.027, p=0.021, and p=0.004 respectively)
in the mortality group. (Table 3) Moreover, the ROC of the
previously proposed predictors (LF, VLF, and DFAa1) and the
new derived parameters (Area5 and Area6–20) were depicted in
Figure 2. Area6–20 (AUC:0.85860.075) showed the best overall
discriminative power than LF (AUC: 0.78460.087), VLF
(AUC:0.73560.117), DFAa1 (AUC:0.7160.145) and Area5
(AUC:0.79460.108) in mortality or heart transplant prediction.
Therefore, Area6–20 was adopted to perform the analysis of
Kaplan-Meier survival curves. The value of Area6–20!21.2 was a
significant predictor of mortality or heart transplant (p=0.0014).
(Figure 3)
Discussion
Although the effects of b-blockers on HRV indices have been
extensively studied [30–32], the effects of b-blockers on MSE are
still unclear. The present study was the first study to assess the
relationship between b-blockers and MSE in CHF patients. The
main findings of this preliminary study were that the b-blocker
therapy may change the short-term complexity (the slope of MSE
between scale 1 to 5). But the most significant predictor of
Table 1. The clinical characteristics between patients with
and without using b-blockers.
Patient characteristics
b-blockers(2)
(n=15)
b-blockers (+)
(n=25) p value
Age (years) 61.7614.7 51.8613.5 p=0.073
Male/Female 9/6 21/4 p=0.158
Heart rate (bpm) 86613 87615 p=0.793
LVEF(%) 33612 35614 p=0.684
Creatinine 1.0760.25 1.1860.35 p=0.280
Fasting sugar (mg/dl) 113647 122647 p=0.573
Triglyceride (mg/dl) 129685 1956177 p=0.189
Cholesterol (mg/dl) 185635 185665 p=0.988
Hemoglobin (g/dl) 13.661.9 13.462.3 p=0.712
Uric acid (mg/dl) 8.963.2 7.162.6 p=0.138
NYHA functional class p=0.660
I 24
II 81 0
III 59
IV 02
Body mass index 25.465.2 25.665.3 p=0.929
Etiology of heart failure p=0.924
Coronary artery disease 6 11
Non-coronary artery Diseases 9 14
Hypertension 4 11
Diabetes mellitus 6 10
Medication p=0.845
ACE-I/ARB 12 19
Loop diuretics 10 18
Digoxin 9 10
Spironolactone 6 7
A total of 40 heart failure patients (30 males and 10 females) were enrolled in
this study. No clinical variable was significantly different between the patients
with or without b-blocker therapy.
NYHA=New York Heart Association; ACE-I=angiotensin converting enzyme
inhibitor; ARB=angiotensin receptor blocker.
doi:10.1371/journal.pone.0018699.t001
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(the area under the MSE curve for scale 6 to 20). Therefore, we
found an alternative prognostic predictor of CHF in addition to
neurohormonal inhibition therapy by assessing the nonlinear
characteristics of the heart rate fluctuations.
Effect of b-blocker therapy on linear and nonlinear
properties of HRV
All linear HRV measurement showed no difference between
patients with or without b-blocker treatment in the present study.
Table 2. Effect of the b-blockers on the autonomic activities,
fractal properties and MSE.
b-blockers(2)
(n=15)
b-blockers(+)
(n=25) p value
Time domain analysis
SDNN 53.2617.8 49.1626.9 p=.332
pNN50 0.9160.85 0.7661.13 p=.100
Frequency domain analysis
HF 31.43620.91 27.9635.3 p=.088
LF 56.3643.0 90.96102.9 p=.659
VLF 484.86321.7 563.06462.9 p=.956
Detrended fluctuation analysis
a1 0.9160.22 1.1060.34 p=.014
a2 1.2760.09 1.2660.18 p=.679
Multiscale entropy
Slope5 20.0260.07 0.0360.08 p=.028
Area5 5.361.2 5.561.1 p=.719
Area6–20 13.163.0 14.362.7 p=.211
While the conventional HRV measurements showed no significant different
between these two groups, nonlinear indices, DFAa1 and the value of Slope5,
were significantly lower in patients without b-blocker therapy.
Slope5=the linear-fitted slope of the first 5 scales, Area5=the summations of
quantitative values of scale 1–5, Area6–20=the summations of quantitative
values of scale 6–20.
doi:10.1371/journal.pone.0018699.t002
Figure 2. Very-low-frequency component (VLF; black, solid
line), low-frequency component (LF; black, dashed line), short-
term fractal exponent (DFAa1; black, dotted line), the summa-
tions of quantitative values of scale 1–5 (Area5; grey, dashed
line), and the summations of quantitative values of scale 6–20
(Area6–20; grey, dash-dotted line) receiver operating charac-
teristic (ROC) curves. The area under each ROC curves (AUC) was
calculated for each parameters. The AUCs were 0.735 for VLF, 0.784 for
LF, 0.701 for DFAa1, 0.794 for Area5, and 0.858 for Area6–20.
doi:10.1371/journal.pone.0018699.g002
Figure 3. Using MSE Area6–20!21.2 as a clinical predictor,
significant difference in survival was noted from the Kaplan-
Meier survival curve (P=0.0014).
doi:10.1371/journal.pone.0018699.g003
Table 3. Prognostic value of parameters of HRV.
Survival
group
(n=34)
Mortality
group
(n=6) p value
Time domain analysis
SDNN 52.8623.5 38.4622.9 p=.225
pNN50 0.8861.09 0.4660.37 p=.939
Frequency domain analysis
HF 32.1632.0 12.669.9 p=.092
LF 87.6690.1 23.3622.6 p=.027
VLF 575.46420.4 297.46290.5 p=.071
Detrended fluctuation analysis
a1 1.0660.27 0.8460.45 p=.127
a2 1.2860.13 1.1560.23 p=.239
Multiscale entropy
Slope5 0.0260.07 20.0360.11 p=.197
Area5 5.661.0 4.561.1 P=.021
Area6–20 22.363.5 16.364.5 p=.004
Among all parameters, Area5, Area6–20, and LF were significantly lower
(p=0.027, p=0.021, and p=0.004 respectively) in the mortality group and
those indices may potentially serve as outcome predictors.
Slope5=the linear-fitted slope of the first 5 scales, Area5=the summations of
quantitative values of scale 1–5, Area6–20=the summations of quantitative
values of scale 6–20.
doi:10.1371/journal.pone.0018699.t003
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function can be assessed by HRV indices [30,31,33]. The
discrepancy between our finding and previous studies could be
due to several factors. The first, the b-blockers were titrated
according to patients’ tolerance in our study. Therefore, the
duration and dosage of b-blockers were variable. The second, the
ECG was recorded 1 month after clinical condition being stable in
our study. However, significant changes of most linear HRV
parameters are found after 12 weeks of treatments. The short-term
fractal scaling correlation index, DFAa1, was markedly higher in
b-blocker group. The reversal of DFAa1 is also reported after
administrating b-blocker in patients with CHF [33]. Our data
showed similar results.
The new nonlinear method, MSE, allows us to evaluate the
information richness in heart beat time series over different time
scales. Although the underlying mechanisms responsible for the
quantitative feature of the MSE in different time scales are still
unclear, previous studies have shown that the complexity
decreased significantly during aging and further deteriorated in
patients with CHF [19]. We applied three different parameters,
Area5, Area6–20, and Slope5, to compare patients with or without
b-blocker treatment. The summation of entropy values at different
time scales may give the quantitative estimation of information
richness over certain time scales. That is, Area5 and Area6–20 can
probe the complexity structure of the heart rate dynamics in short
(e.g., 1 to 5 heart beats) and longer (e.g., 6 to 20 heart beats) time
scales, respectively. The Slope5 also outlined the structure of heart
rate dynamics in short time scale [19]. The negative value of
Slope5 indicates random-like patterns in short time scales.
Therefore, the significant difference between b-blocker and non
b-blocker groups might due to dysfunction of the short-term
regulatory mechanisms coincided with the results assessed by
DFAa1.
Complexity analysis as a prognosis predictor
Applying Fourier-based method to nonlinear or nonstationary
signals may result in inaccurate estimations [9,29] and compro-
mise the sensitivity of linear HRV measurements. Recently,
DFAa1 has been proposed to be a better predictor for CHF
patients [34]. In the present study, SDNN and DFAa1 failed to
predict the prognosis of CHF patients. Makikallio et al. noticed that
HRV indexes such as SDNN is less sensitive in CHF patient with
NYHA.III [35]. Sixteen patients (40%) were classified as NYHA
III–IV in our study and five out of them were in mortality group.
Moreover, administration of beta-blockade has shown a reversal
effect in either linear and nonlinear parameters such as SDNN,
HF, LF and DFAa1 [30,32,33]. Half of the patients with poor
outcome were treated with beta blocker which may potentially
influence the parameters. SDNN and DFAa1 may be, therefore,
insensitive to predict their prognosis. Area5 and Area6–20 derived
from MSE were markedly lower in the mortality group. This
phenomenon was in agreement with those found by Costa et al. in
MUSIC study [19]. Although the underlying mechanisms were
still unclear, this preliminary study provided a new insight for the
prognosis of CHF by probing the dynamical complexity on the
system level. It could potentially offer an alternative marker for the
outcome of CHF in addition to neurohormonal inhibition therapy.
Limitations of study
First, our study had small sample size and no placebo-controlled
group. Second, all ECG data were recorded in normal ‘‘free-
running’’ conditions with possible confounding factors (e.g.,
physical activities, different breathing patterns, and so on). The
additive or dynamical noises may affect the properties of the
signals. Although we examined and interpreted the results of the
analysis cautiously and the differences characteristics of the
patients were unlikely due to the noise, we did not assess the
features or level of noise for more detailed information that may
benefit the exploration of the underlying deterministic rules.
Finally, some parameters related to possible physiological
mechanisms of MSE were not collected, such as baroreflex
sensitivity, catecholamine levels, and chemoreflex activities.
In conclusions, the area under the MSE curve for scale 6 to 20 is
not relevant to b-blockers and could further warrant independent
risk stratification for the prognosis of CHF patients.
Supporting Information
Figure S1 The 4-hour time tracings of RR intervals of
survived patient (A) and patient who died after 1 year (B)
and the return map traits of three-dimensional RR time
series reconstruction (x-axis for RRn, y-axis for RRn+1
and z-axis for RRn+2) of survived patient (C) and expired
patients (D). Note that the trait of the map in survival patient
was similar to that in expired patient.
(TIFF)
Materials S1 The RR intervals of each patient was
output in a one-column Ascii file and categorized into
two groups according to their outcomes after 2.5 years
follow up. All of the files were packed into a compressed RAR
file.
(RAR)
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